BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18644526)

  • 1. Unilateral vesicoureteral reflux: does endoscopic injection based on the cystoscopic appearance of the ureteral orifice decrease the incidence of de-novo contralateral reflux?
    Routh JC; Inman BA; Ashley RA; Vandersteen DR; Reinberg Y; Wolpert JJ; Kramer SA; Husmann DA
    J Pediatr Urol; 2008 Aug; 4(4):260-4. PubMed ID: 18644526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience.
    Kirsch AJ; Perez-Brayfield MR; Scherz HC
    J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical Outcome Analysis of Pneumovesicoscopic Ureteral Reimplantation and Endoscopic Dextranomer/Hyaluronic Acid Injection for Primary Vesicoureteral Reflux in Children: A Multicenter 12-Year Review.
    Chung KLY; Sihoe J; Liu K; Chao N; Hung J; Liu C; Yam F; Leung Y; Tam P; Lee KH; Leung M
    J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):348-353. PubMed ID: 29271690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of dextranomer/hyaluronic acid injection in setting of bladder and ureteral anomalies.
    Routh JC; Kramer SA; Inman BA; Ashley RA; Wolpert JJ; Vandersteen DR; Husmann DA; Reinberg Y
    Urology; 2008 Mar; 71(3):435-8. PubMed ID: 18342182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR).
    García-Aparicio L; Blázquez-Gómez E; Martin O; Pérez-Bertólez S; Arboleda J; Soria A; Tarrado X
    World J Urol; 2018 Oct; 36(10):1651-1656. PubMed ID: 29725806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral vesicoureteral reflux and history of contralateral vesicoureteral reflux warranting routine bilateral endoscopic correction.
    Chertin B; Natsheh A; Fadeev D; Shenfeld OZ; Farkas A
    J Urol; 2008 Oct; 180(4 Suppl):1601-3; discussion 1604. PubMed ID: 18710733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are there predictive factors for the outcome of endoscopic treatment of grade III-V vesicoureteral reflux with dextranomer/hyaluronic acid in children?
    Altug U; Cakan M; Yilmaz S; Yalçinkaya F
    Pediatr Surg Int; 2007 Jun; 23(6):585-9. PubMed ID: 17356857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ureteral Obstruction After Endoscopic Treatment of Vesicoureteral Reflux: Does the Type of Injected Bulking Agent Matter?
    Friedmacher F; Puri P
    Curr Urol Rep; 2019 Jul; 20(9):49. PubMed ID: 31289951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic vesicoureteral reflux correction in transplanted kidneys: does injection technique matter?
    Yucel S; Akin Y; Celik O; Erdogru T; Baykara M
    J Endourol; 2010 Oct; 24(10):1661-4. PubMed ID: 20626270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic treatment of primary grade V vesicoureteral reflux using hyaluronic acid copolymer (DX/HA).
    Hunziker M; Mohanan N; D'Asta F; Puri P
    Pediatr Surg Int; 2010 Oct; 26(10):977-9. PubMed ID: 20625750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic treatment of grades IV and V vesicoureteral reflux with two bulking substances: Dextranomer hyaluronic acid copolymer versus polyacrylate polyalcohol copolymer in children.
    Kocaoglu C
    J Pediatr Surg; 2016 Oct; 51(10):1711-5. PubMed ID: 27117052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study of endoscopic treatment in children with primary vesicoureteral reflux and multivariate analysis of factors for failure.
    Akin Y; Gulmez H; Güntekin E; Baykara M; Yucel S
    Scand J Urol; 2014 Dec; 48(6):565-70. PubMed ID: 25028806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic injection of dextranomer hyaluronic acid copolymer for the treatment of vesicoureteral reflux in duplex ureters.
    Molitierno JA; Scherz HC; Kirsch AJ
    J Pediatr Urol; 2008 Oct; 4(5):372-6. PubMed ID: 18790423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single center experience with endoscopic management of vesicoureteral reflux in children.
    Routh JC; Vandersteen DR; Pfefferle H; Wolpert JJ; Reinberg Y
    J Urol; 2006 May; 175(5):1889-92; discussion 1892-3. PubMed ID: 16600790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New contralateral vesicoureteral reflux following dextranomer/hyaluronic Acid implantation: incidence and identification of a high risk group.
    Elmore JM; Kirsch AJ; Lyles RH; Perez-Brayfield MR; Scherz HC
    J Urol; 2006 Mar; 175(3 Pt 1):1097-100; discussion 1100-1. PubMed ID: 16469630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective endoscopic treatment of the non-refluxing contralateral ureter prevents new contralateral vesicoureteral reflux.
    Cerwinka WH; Kaye JD; Leong TL; Elmore JM; Scherz HC; Kirsch AJ
    J Pediatr Urol; 2013 Feb; 9(1):51-5. PubMed ID: 22177779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic treatment with dextranomer/hyaluronic acid for complex cases of vesicoureteral reflux.
    Perez-Brayfield M; Kirsch AJ; Hensle TW; Koyle MA; Furness P; Scherz HC
    J Urol; 2004 Oct; 172(4 Pt 2):1614-6. PubMed ID: 15371773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The correlation between ureteric orifice morphology and primary vesicoureteral reflux grade and the impact on the effectiveness of endoscopic reflux correction.
    Zvizdic Z; Catic A; Zivojevic S; Jonuzi A; Glamoclija U; Vranic S
    J Pediatr Urol; 2024 Apr; 20(2):295-301. PubMed ID: 37940510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Intravesical Ureters after Failed Endoscopic Treatment of Vesicoureteral Reflux with Dextranomer/hyaluronic Acid in Children via Light and Transmission Electron Microscopic Analysis. A Matched Case-Control Study.
    Izol V; Kuyucu Y; Acikalin A; Deger M; Aridogan IA; Polat S; Satar N
    Urol J; 2019 Jun; 16(3):279-284. PubMed ID: 30178448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine delayed voiding cystourethography after initial successful endoscopic treatment with Dextranomer/Hialuronic Acid Copolimer (Dx/HA) of vesicoureteral reflux (VUR). Is it necessary?
    García-Aparicio L; Blázquez-Gómez E; Vila Santandreu A; Camacho Diaz JA; Vila-Cots J; Ramos Cebrian M; de Haro I; Martin O; Tarrado X
    Actas Urol Esp; 2016 Dec; 40(10):635-639. PubMed ID: 27161091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.